About Aradigm
Aradigm is a public benefit corporation and benefits platform for cell and gene therapies (CGTs), built to make life-saving medicines affordable and accessible at a national scale. It creates a large-scale risk pool to cover CGT drugs and care, operating on a cost-plus, transparent pricing model with unspent funds returned to payers. Its customers include self-insured employers, health plans, providers, and manufacturers seeking sustainable, equitable access to high-cost curative therapies.
Company details
Funding
Total raised
$25M
Last stage
Series A
Investors
Founders
William Shrank
Internal medicine physician and former researcher at Harvard Medical School. Previously served as Chief Medical Officer at Humana and UPMC Health Plan, led value-based payment models at CMS, and shaped care delivery partnerships at CVS Health. Also served as a venture partner at Andreessen Horowitz.
LinkedIn
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.